Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients

Hypertension

Volumn 30, Issue 6, 1997, Pages 1606-1612

  Taddei, Stefano ^a   Virdis, Agostino ^a   Ghiadoni, Lorenzo ^a   Uleri, Stefano ^a   Magagna, Armando ^a   Salvetti, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Acetylcholine; Bradykinin; Endothelium; Essential; Hypertension

Indexed keywords

ACETYLCHOLINE; BRADYKININ; LACIDIPINE; NITROPRUSSIDE SODIUM;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; THROMBOCYTE AGGREGATION; VASODILATATION;

EID: 0030693948     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.6.1606     Document Type: Article

References (56)

1. Lüscher TF, Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Function. Boca Raton, Fla: CRC Press; 1990.
2. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
3. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
4. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
5. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 1991;351:714.
6. Vallance P, Coller J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2: 997-1000.
7. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level. J Am Coll Cardiol. 1994;23:1610-1616.
8. Panza JA, Garcìa CE, Kilcoyne CM, Quyyumi A, Cannon RO III. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that nitric oxide abnormality is not localised to a single signal transduction pathway. Circulation. 1995; 91:1732-1738.
9. Lüscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of spontaneously hypertensive rats. Hypertension. 1986;8:344-348.
10. 2 in endothelium in maintaining resting tone and producing contractile response to acetylcholine and arachidonic acid in canine cerebral artery. Blood Vessels. 1987;24:117-119.
11. 2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. Hypertension. 1990;15:475-482.
12. Katusic ZS, Vanhoutte PM. Superoxide anion is an endothelium- derived contracting factor. Am J Physiol. 1989;257:H33-H37.
13. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factors. Am J Physiol. 1986; 250:H822-H827.
14. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion plays a role in the breakdown of endothelium-derived relaxing factor. Nature. 1986;320:454-456.
15. Mügge A, Elwell JH, Peterson TE, Harrison DG. Release of intact endothelium-dependent relaxing factor depends on endothelial superoxide dismutase activity. Am J Physiol. 1991;260:C219-C225.
16. Vanhoutte PM. Endothelium and control of vascular function: state of the art lecture. Hypertension. 1989;13:658-667.
17. Under L, Kiowski W, Bühler, Lüscher TF. Indirect evidence for the release of endothelium-derived relaxing factor in the human forearm circulation in vivo: blunted response in essential hypertension. Circulation. 1990;81:1762-1767.
18. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
19. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993;21:929-933.
20. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium- dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87:1468-1474.
21. Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation. 1993;87: 1475-1481.
22. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Basile Fasolo C, Sudano I, Salvetti A. Aging and endothelial function in normotensive subjects and essential hypertensive patients. Circulation. 1995;91:1981-1987.
23. Taddei S, Virdis A, Mattei P, Natali A, Ferrannini E, Salvetti A. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. Circulation. 1995;92:2911-2918.
24. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension. 1997;29(pt 2):274-279.
25. Taddei S, Virdis A, Mattei P, Ghiadoni L, Basile Fasolo C, Sudano I, Salvetti A. Hypertension causes premature aging of endothelial function in humans. Hypertension. 1997;29:736-743.
26. Lüscher TF. The endothelium in hypertension: bystander, target or mediator? J Hypertens. 1994;12(suppl 10):S105-S116.
27. Lüscher TF, Raij L, Vanhoutte PM. Effect of hypertension and its reversal on endothelium-dependent relaxation in the aorta of the rat. J Hypertens. 1987;5(suppl 5):153-155.
28. Lüscher TF, Vanhoutte PM, Raij L. Antihypertensive treatment normalizes decreased endothelium-dependent relaxations in rats with salt-induced hypertension. Hypertension. 1987;9:193-197.
29. Clozel M, Kuhn H, Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension. 1990;16:532-540.
30. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol. 1993;21:1145-1151.
31. Creager MA, Roddy MA. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension. 1994; 24:499-505.
32. Kiowski W, Linder L, Nuesch R, Martina B. Effect of cilazapril on vascular structure and function in essential hypertension. Hypertension. 1996;27(pt 1):371-376.
33. 2+-antagonists. J Cardiovasc Pharmacol 1988;12(suppl 6):21-28.
34. Tschudi MR, Criscione L, Novosel D, Pfeiffer K, Lüscher TF. Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats. Circulation. 1994;89:2212-2218.
35. Takase H, Moreau P, Küng CF, Nava E, Lüscher TF. Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency: effect of verapamil and trandolapril. Hypertension. 1996;27:25-31.
36. Schultz KD, Schultz K, Schultz G. Sodium nitroprusside and other smooth muscle relaxants increase cyclic GMP levels in rat ductus deferens. Nature. 1977;265:750-751.
37. Whitney RJ. The measurement of volume changes in human limbs. J Physiol (Lond). 1953;121:1-27.
38. Pedrinelli R, Taddei S, Graziadei L, Salvetti A. Vascular responses to ouabain and norepinephrine in low and normal renin hypertension. Hypertension. 1986;8:786-792.
39. Frielingsdorf J, Seiler C, Kaufmann P, Vassalli G, Suter T, Hess OM. Normalization of abnormal coronary vasomotion by calcium antagonists in patients with hypertension. Circulation. 1996;93: 1380-1387.
40. Schiffrin LE, Deng LY. Structure and function of resistance arteries of hypertensive patients treated with a β-blocker or a calcium channel antagonist. J Hypertens. 1996;14:1247-1255.
41. Flavahan NA, Shimokawa H, Vanhoutte PM. Pertussis toxin inhibits endothelium-dependent relaxations to certain agonists in porcine coronary arteries. J Physiol 1989;408:549-560.
42. Flavahan NA, Shimokawa H, Vanhoutte PM. Inhibition of endothelium-dependent relaxation by phorbol myristate acetate: role of a pertussis toxin-sensitive G-protein. J Pharmacol Exp Ther. 1991; 256:50-55.
43. Johns A, Freay AD, Adams DJ, Lategan TW, Ryan US, van Breemen C. Role of calcium in the activation of endothelial cells. J Cardiovasc Pharmacol. 1988;12(suppl 5):119-123.
44. Lamas L, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA. 1992;89:6348-6352.
45. Himmel HM, Whorton AR, Strauss HC. Intracellular calcium, currents and stimulus-response coupling in endothelial cells. Hypertension. 1993;21:112-117.
46. Lupo E, Locher R, Weisse B, Vetter W. In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with α-tocopherol. Biochem Biophys Res Commun. 1994;203:1803-1808.
47. Mak TI. Boehme P, Weglicki WB. Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells. Circ Res. 1992;70:1099-1103.
48. Van Amsterdam FThM, Roveri A. Maiorino M, Ratti E, Ursini F. Lacidipine: a dihydropyridine calcium antagonist with antioxidant activity. Free Radical Biol Med. 1992;12:183-187.
49. Virdis A, Taddei S, Ghiadoni L, Salvetti A. Effect of vitamin C on vasodilation to acetylcholine in the forearm of essential hypertensive patients. Hypertension. 1996;28:695. Abstract.
50. Zeiher AM, Drexter H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest. 1993;92:652-662.
51. Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I, Bernini G, Pinto S, Salvetti A. Menopause is associated with endothelial dysfunction in women. Hypertension. 1996;28:576-582.
52. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 1993;88: 2510-2516.
53. Kiowski W, Linder L, Stoschitzky K. Pfistererm M, Burckhardt D, Burkart F. Bühler FR. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation. 1994;90:27-34.
54. Yasue H, Matsuyama K, Matsuyama K, Okamura K, Morikami Y, Ogawa H. Response of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment: possible role of early coronary atherosclerosis. Circulation. 1990;81:482-490.
55. Heitzer T, Ylä-Herttauala S, Luoma J, Kurz S, Münzel T, Just H, Olschewski M, Drexler H. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: role of oxidized LDL. Circulation. 1996;93: 1346-1353.
56. Bond G, Dal Palú C, Hansson L, Magnani B, Mancia G, Neiss A, Rahn KH, Reid JL, Rodicio JL, Safar M, Zanchetti A. The ELSA trial: protocol of a randomised trial to explore the differential effect of antihypertensive drugs on atherosclerosis in hypertension. J Cardiovasc Pharmacol. 1994;23(suppl 5):S85-S87.